SEC Form D · filed October 10, 2017
Engage Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Gregory Mayes · Summit, NJExec · Director · PromoterGerry D. Brunk · Weston, MADirectorStephen D. Collins · Lake Forest, ILDirectorOrrin Devinsky · New York, NYDirectorJouko D. Isojarvi · Durham, NCExecHeath D. Lukatch · Fort Worth, TXDirectorWarren Lammert · Boston, MADirectorCaledonia (Private) Investments Pty Limited · SYDNEY NSW, Channel IslandsExecDouglas F. Blough · NASHUA, NHDirectorSam Eletr · San Francisco, CADirectorBruce S. Macdonald · NASHUA, NHExec · Director · PromoterSire Management Corporation · New York, NYDirectorDominik W. Pozny · New York, NYDirectorSire Management Partners, L.P · New York, NYDirectorDavid Kittle · San Diego, CADirectorDavid Gastfriend · BOSTON, MAExecThomas Gravina · Exton, PAExec · Director · PromoterFrederick Jones · Exton, PADirectorRichard Vague · Exton, PADirectorVirginia Stallings · Exton, PADirectorJames O'Connell · Exton, PADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗